CDKN2B and neoplasm: CDKN2B-AS1 is a potential lncRNA that has been shown to be aberrantly expressed in various malignancies and involved in the processes of tumor cells proliferation, migration, invasion, and inhibition of tumor cells apoptosis [26–28].